1. Naturally occurring B-cell responses to breast cancer

   • Julia A. Coronella-Wood
   • Evan M. Hersh

   Review 15 August 2003 Pages: 715 - 738

   

2. Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model

   • Maryam Parviz
   • Cynthia S. Chin
   • Harry D. Bear

   Original Article 14 August 2003 Pages: 739 - 750

   

3. Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication

   • Joseph Lustgarten

   Original Article 19 June 2003 Pages: 751 - 760

   

4. Identification of new MHC-restriction elements for presentation of the p210^BCR-ABL fusion region to human cytotoxic T lymphocytes

   • Ji-Yao Sun
   • David Senitzer
   • K. K. Wong Jr

   Original Article 17 October 2003 Pages: 761 - 770

   

5. Natural CD8⁺ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors

   • Panagiota A. Sotiropoulou
   • Sonia A. Perez
   • Constantin N. Baxevanis

   Original Article 10 September 2003 Pages: 771 - 779

   

6. Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma

   • Monique R. Bernsen
   • Toon F. C. M. Smetsers
   • Annika Håkansson

   Short Communication 10 September 2003 Pages: 780 - 783